Vaxart, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 10, 2018 and accepted by EDGAR at Aug 10, 2018, 16:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $608.0k | us-gaap:Revenues |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $2.1m | us-gaap:Revenues |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $5.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $8.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$7.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | −$11.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-04-01 to 2018-06-30 | $136.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2018-01-01 to 2018-06-30 | $573.0k | us-gaap:InterestExpense |
| Income tax | 3 months2018-04-01 to 2018-06-30 | $1.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | $29.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$8.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | −$6.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | −$1.26 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$3.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $339.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-06-30 | $23.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $25.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $47.8m | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $8.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $25.4m | us-gaap:Liabilities |
| Long-term debt | At period end2018-06-30 | $17.1m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2018-06-30 | $22.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001513162-18-000192. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.